Wang et al. reported the synergetic effect of apigenin in combination with TMZ against TMZ-resistant GBM cells by increasing the chemosensitivity of TMZ by decreasing MMP-2 and 9, BCL-2, AKT phosphorylation, and cyclin D1 [285]. The gene discussed is MMP2; the disease is glioblastoma.